Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Household Humidifier Market Growth & Trends
The global household humidifier market size is expected to reach USD 4.93 billion in 2030 and is projected to grow at a CAGR of 4.7% from 2024 to 2030. Rising awareness about the health effects of dry air, including dry throat, nose irritation, dry cough, sinus congestion, dry skin, and bloody noses, is driving the growth. Rising demand for the product from houseplant owners to maintain a specific level of indoor humidity, is also projected to further fuel the demand.
These products have low operational cost as they require very less electricity. Several smart whole-home products automatically adjust the humidity level based on the temperature of the home and they require very little maintenance. These products are connected to the central HVAC system of the home which maintains the humidity of the entire home. Such advantages of the product are anticipated to bode well for the segment growth.
These channels are expected to remain a key medium as they provide after-sale-services including installation, maintenance, and repair. Online channel, on the other hand, is expected to witness the fastest CAGR, owing to the rapid adoption of e-commerce as a purchasing medium owing to the convenience, add-on services such as Cash-on-Delivery (COD), cashback offers, coupon benefits, and free home delivery. Additionally, increasing digitalization in developing economies including China and India on account of supportive government policies for improving internet connectivity along with smartphone penetration is anticipated to drive the growth.
High consumer awareness about the negative effects of low humidity or dry air and the cold weather conditions in U.S. and Canada are projected to continue driving the regional product demand during the forecast period. The product sales fluctuate during cold and warm seasons due to the weather dependency of the product.
Key participants operating in the market for household humidifiers include Jarden Corporation; Boneco AG (Air-O-Swiss); Aprilaire; Dyson Ltd; Crane USA; Honeywell International Inc.; Essick Air Products, Inc.; Hunter Home Comfort; Guardian Technologies; Venta Air Technologies, Inc.; and Stadler Form Aktiengesellschaft.
Household Humidifier Market Report Highlights
Household Humidifier Market Growth & Trends
The global household humidifier market size is expected to reach USD 4.93 billion in 2030 and is projected to grow at a CAGR of 4.7% from 2024 to 2030. Rising awareness about the health effects of dry air, including dry throat, nose irritation, dry cough, sinus congestion, dry skin, and bloody noses, is driving the growth. Rising demand for the product from houseplant owners to maintain a specific level of indoor humidity, is also projected to further fuel the demand.
These products have low operational cost as they require very less electricity. Several smart whole-home products automatically adjust the humidity level based on the temperature of the home and they require very little maintenance. These products are connected to the central HVAC system of the home which maintains the humidity of the entire home. Such advantages of the product are anticipated to bode well for the segment growth.
These channels are expected to remain a key medium as they provide after-sale-services including installation, maintenance, and repair. Online channel, on the other hand, is expected to witness the fastest CAGR, owing to the rapid adoption of e-commerce as a purchasing medium owing to the convenience, add-on services such as Cash-on-Delivery (COD), cashback offers, coupon benefits, and free home delivery. Additionally, increasing digitalization in developing economies including China and India on account of supportive government policies for improving internet connectivity along with smartphone penetration is anticipated to drive the growth.
High consumer awareness about the negative effects of low humidity or dry air and the cold weather conditions in U.S. and Canada are projected to continue driving the regional product demand during the forecast period. The product sales fluctuate during cold and warm seasons due to the weather dependency of the product.
Key participants operating in the market for household humidifiers include Jarden Corporation; Boneco AG (Air-O-Swiss); Aprilaire; Dyson Ltd; Crane USA; Honeywell International Inc.; Essick Air Products, Inc.; Hunter Home Comfort; Guardian Technologies; Venta Air Technologies, Inc.; and Stadler Form Aktiengesellschaft.
Household Humidifier Market Report Highlights
- Ultrasonic is expected to witness the fastest CAGR of 5.2% during the forecast period
- The offline segment dominated the market in 2023. The growth can be attributed to a rise in specialty store shopping as these stores focus on products such as electronic or home appliances etc
- Portable household humidifier dominated the market and accounted for a share of 91.7% in 2023
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. HUMAN EMBRYONIC STEM CELLS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Human Embryonic Stem Cells Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
CHAPTER 4. HUMAN EMBRYONIC STEM CELLS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Human Embryonic Stem Cells Market: Application Movement Analysis, 2023 & 2030 (USD Million)
4.3. Regenerative Medicine
4.3.1. Regenerative Medicine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Stem Cell Biology Research
4.4.1. Stem Cell Biology Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Tissue Engineering
4.5.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Toxicology Testing
4.6.1. Toxicology Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. HUMAN EMBRYONIC STEM CELLS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Human Embryonic Stem Cells Market Share, By Region, 2023 & 2030 (USD Million)
5.2. North America
5.2.1. North America Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Mexico Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. UK Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. France Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Sweden Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Norway Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. China
5.4.2.1. China Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Japan
5.4.3.1. Japan Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. South Korea
5.4.5.1. South Korea Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Australia
5.4.6.1. Australia Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Saudi Arabia Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. UAE
5.6.3.1. UAE Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. South Africa
5.6.4.1. South Africa Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. Thermo Fisher Scientific, Inc.
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. STEMCELL Technologies
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Merck KGaA
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. CellGenix GmbH
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. PromoCell GmbH
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. Takara Bio
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. Lonza
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. Cellartis AB
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives
6.4.9. ATCC
6.4.9.1. Participant’s Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Recent Developments/ Strategic Initiatives
6.4.10. AcceGen
6.4.10.1. Participant’s Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Recent Developments/ Strategic Initiatives
6.4.11. Cell Applications, Inc.
6.4.11.1. Participant’s Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Recent Developments/ Strategic Initiatives
6.4.12. Bio-Techne
6.4.12.1. Participant’s Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. HUMAN EMBRYONIC STEM CELLS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Human Embryonic Stem Cells Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
CHAPTER 4. HUMAN EMBRYONIC STEM CELLS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Human Embryonic Stem Cells Market: Application Movement Analysis, 2023 & 2030 (USD Million)
4.3. Regenerative Medicine
4.3.1. Regenerative Medicine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Stem Cell Biology Research
4.4.1. Stem Cell Biology Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Tissue Engineering
4.5.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Toxicology Testing
4.6.1. Toxicology Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. HUMAN EMBRYONIC STEM CELLS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Human Embryonic Stem Cells Market Share, By Region, 2023 & 2030 (USD Million)
5.2. North America
5.2.1. North America Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Mexico Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. UK Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. France Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Sweden Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Norway Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. China
5.4.2.1. China Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Japan
5.4.3.1. Japan Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. South Korea
5.4.5.1. South Korea Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. Australia
5.4.6.1. Australia Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. Saudi Arabia
5.6.2.1. Saudi Arabia Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. UAE
5.6.3.1. UAE Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. South Africa
5.6.4.1. South Africa Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. Thermo Fisher Scientific, Inc.
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. STEMCELL Technologies
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Merck KGaA
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. CellGenix GmbH
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. PromoCell GmbH
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. Takara Bio
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. Lonza
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. Cellartis AB
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives
6.4.9. ATCC
6.4.9.1. Participant’s Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Recent Developments/ Strategic Initiatives
6.4.10. AcceGen
6.4.10.1. Participant’s Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Recent Developments/ Strategic Initiatives
6.4.11. Cell Applications, Inc.
6.4.11.1. Participant’s Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Recent Developments/ Strategic Initiatives
6.4.12. Bio-Techne
6.4.12.1. Participant’s Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Recent Developments/ Strategic Initiatives
